Account
Insider Insights
17.02.2022
Paracetamol and Ibuprofen combination available

The switch from prescription to non-prescription status was recommended by the Federal Institute for...

Read more
Insider Insights
09.02.2022
CMA fines firms 35 million

The actions of the companies meant that from December 2013 to December 2017, the price paid by the N...

Read more
Insider Insights
01.02.2022
Self-care market growth

According to the association, the growth in the market was expected and can be explained by two fact...

Read more
Articles
06.10.2021
PMA Perspective Q3 2021

Insights from pharmaceuticals, market access and Team Remap Q3 2021.

Read more
News
15.09.2021
PMA Insight: Week 37 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
06.09.2021
Real world evidence

Real-world evidence (RWE) refers to clinical and economic evidence which has been derived from the a...

Read more
Articles
06.08.2021
Healthcare performance comparison summary

The Common Wealth Fund has recently released a healthcare performance comparison report between 11 c...

Read more
Articles
04.05.2021
What is the difference between RWE & RWD

Real-world evidence (RWE) is increasingly playing an important role in developing product value prop...

Read more
Articles
20.01.2021
What is a Value Proposition

For an audience to properly understand the value of a drug, evidence needs to be put into context.

Read more
Articles
26.10.2020
What is critical appraisal of evidence

When critically appraising a clinical study, it is key to firstly identify the sources of uncertaint...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.